These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33415090)

  • 21. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.
    Markham AJ; Rasmussen SE; Salmon JE; Martinez-Ortiz W; Cardozo TJ; Clancy RM; Buyon JP
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.
    Clancy RM; Markham AJ; Jackson T; Rasmussen SE; Blumenberg M; Buyon JP
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H631-H640. PubMed ID: 28626076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
    Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML
    J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.
    Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P
    Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.
    Hoxha A; Ruffatti A; Ambrosi A; Ottosson V; Hedlund M; Ottosson L; Anandapadamanaban M; Sunnerhagen M; Sonesson SE; Wahren-Herlenius M
    Clin Exp Immunol; 2016 Dec; 186(3):284-291. PubMed ID: 27548532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.
    Tonello M; Ruffatti A; Marson P; Tison T; Marozio L; Hoxha A; De Silvestro G; Punzi L
    Transfusion; 2015 Jul; 55(7):1782-6. PubMed ID: 25825254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.
    Gleicher N; Elkayam U
    Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.
    Lisney AR; Szelinski F; Reiter K; Burmester GR; Rose T; Dörner T
    Ann Rheum Dis; 2017 Aug; 76(8):1476-1480. PubMed ID: 28501799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
    Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center.
    Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G
    Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.
    Brito-Zerón P; Pasoto SG; Robles-Marhuenda A; Mandl T; Vissink A; Armagan B; Praprotnik S; Nocturne G; Sebastian A; Fernandes Moça Trevisani V; Retamozo S; Acar-Denizli N; Wiland P; Sisó-Almirall A; Bootsma H; Mariette X; Ramos-Casals M; Kostov B;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):95-102. PubMed ID: 33025893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and ionic basis of congenital complete heart block.
    Boutjdir M
    Trends Cardiovasc Med; 2000 Apr; 10(3):114-22. PubMed ID: 11427998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.